<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03196895</url>
  </required_header>
  <id_info>
    <org_study_id>19370</org_study_id>
    <secondary_id>1R01DK108957</secondary_id>
    <nct_id>NCT03196895</nct_id>
  </id_info>
  <brief_title>Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification</brief_title>
  <official_title>Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conventional lifestyle modification in the management of type 2 diabetes focuses on weight
      loss, through caloric restriction and exercise, to reduce insulin resistance. This approach
      is limited because some people either do not need to lose weight, do not want to lose weight,
      cannot lose weight, or cannot maintain weight loss over a lifetime. This study proposes to
      evaluate the effectiveness of a lifestyle modification that focuses on reducing post-meal
      blood glucose (BG) elevations instead of weight loss. It works by teaching participants to:
      1) choose low glycemic load foods that do not significantly increase their blood glucose, and
      2) increase their routine physical activity after meals when it can offset post-meal blood
      glucose elevations. The study will also evaluate the role feedback about blood glucose
      fluctuations can play in improving the effectiveness of this program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Type 2 diabetes (T2D) is a growing epidemic in the U.S. with devastating
      complications that result in major health and personal costs. To address this, the American
      Diabetes Association recommends a lifestyle program that focuses on weight loss through
      caloric restriction and exercise as an initial or an adjunct treatment to pharmacological
      interventions. However, its general applicability is limited because some individuals with
      T2D do not need to lose weight, do not want to lose weight, cannot lose weight, or cannot
      maintain weight loss over a lifetime. Recent research indicates that a major contributor to
      poor metabolic control is postprandial glucose (PPG) elevation. The researchers have
      developed a treatment option that focuses on reducing PPG without requiring weight loss. This
      lifestyle program is comprehensive, integrated, and efficient. Over 5 sessions, this program
      empowers individuals to use Glycemic load of food, Exercise, and Monitoring glucose (GEM) in
      a systematic manner. GEM's 1.03% HbA1c reduction compared favorably to both conventional
      weight loss (0.64% reduction with 42 sessions of Look AHEAD) and continual use of a first
      line medication (0.9% reduction with Metformin). When enhancing the quantity and quality of
      glucose feedback with Continuous Glucose Monitoring (CGM), GEM reduced HbA1c by 1.30%.

      AIMS: This project will determine how GEM compares to conventional weight reduction at short-
      and long-term follow-up in a large, representative sample of adults with type 2 diabetes. At
      the same time, the researchers will test a conceptual model based on a review of the
      literature postulating that the effects of GEM are modulated by the quality and quantity of
      glucose feedback. This has important implications for long-term maintenance; since the model
      proposes a cascade in which increasing either the quantity or quality of glucose feedback
      improves immediate behavior change through positive and negative glucose consequences. These
      contingencies may lead to improved PPG and insulin sensitivity, and in turn, improved
      metabolic control. This cascade may produce ancillary benefits that could help maintain
      long-term success, e.g. greater empowerment and fewer depressive symptoms.

      APPROACH: 200 participants with poorly controlled T2D will be randomized to 1 of 4 groups
      that manipulate both the focus on postprandial glucose and the quality and quantity of
      glucose feedback. Short- and long-term benefits will be assessed using medical, behavioral
      and psychological measures obtained at baseline, 3 months post-intervention and 12 months
      post-intervention.

      IMPACT: If GEM is shown to be effective and enduring, it will provide an alternative to the
      conventional weight-loss focused lifestyle modification. GEM has the potential to improve
      metabolic control, increase self-reliance, and slow disease progression. Because GEM is
      manual-based, it will be easy to deploy and will give it the potential to impact a large
      proportion of the adults with T2D.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2017</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in HbA1c</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>change in HbA1c from baseline measure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in medication</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>change in medication type or dose from baseline measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in food choices (ASA24 survey)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>ASA24 survey across 3 separate days in each time frame</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in food choices (energy bar selection)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>At assessment visits, subjects will choose between energy bars that do or dont support the intervention principles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in physical activity (Fitbit activity monitor)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>daily activity will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (dietary habits questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>The Food Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (quality of life questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>WHOQO-BREF questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (depression questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>Patient Health Questionnaire (PHQ-9)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (numeracy questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>Numeracy Scale - measures how good one is with numbers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (diabetes knowledge questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>Diabetes Knowledge Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (empowerment questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>Diabetes Empowerment Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (concerns about diabetes questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>Diabetes Distress Scale (Emotional Distress &amp; Regimen Distress subscales)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in psychological functioning (attitude towards glucose monitoring questionnaire)</measure>
    <time_frame>baseline, 3 months, and 12 months post-intervention</time_frame>
    <description>The Glucose Monitoring Satisfaction Survey (GMSS)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>WR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Weight reduction training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PPG training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GEM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PPG training + discrete BG feedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GEM+CGM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PPG training + continuous BG feedback</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Weight reduction training</intervention_name>
    <description>6 one-hour sessions of conventional weight reduction training</description>
    <arm_group_label>WR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PPG training</intervention_name>
    <description>Four 90-minute sessions of glycemic load and exercise training</description>
    <arm_group_label>GE</arm_group_label>
    <arm_group_label>GEM</arm_group_label>
    <arm_group_label>GEM+CGM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>discrete BG feedback</intervention_name>
    <description>Blood glucose feedback from structured self-monitoring of blood glucose</description>
    <arm_group_label>GEM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>continuous BG feedback</intervention_name>
    <description>blood glucose feedback from continuous glucose monitoring</description>
    <arm_group_label>GEM+CGM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with T2D in the last 10 years

          -  HbA1c &gt;7.5% (sub-optimal T2D control)

          -  Between 21 and 80 years old

          -  Not blind

          -  Can read English

          -  Routinely uses a smart phone

        Exclusion Criteria:

          -  Takes insulin (participants may start insulin during the study if clinically
             indicated)

          -  Has taken medications that impede weight loss (e.g., prednisone) within the last 3
             months

          -  Currently pregnant or contemplating pregnancy within the next 15 months

          -  Conditions that preclude increasing physical activity (e.g. severe neuropathy
             cardiovascular disease, chronic obstructive pulmonary disease/emphysema,
             osteoarthritis, stroke, or severe mental disease like manic depressive illness, severe
             depression, active substance abuse)

          -  Undergoing treatment for cancer

          -  History of lactic acidosis

          -  Marked renal impairment (eGFR &lt; 45; stage 3b chronic kidney disease)

          -  Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics)

          -  Cannot read English

          -  Blindness

          -  Cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel J Cox, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Psychiatry and Neurobehavioral Sciences, University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tom A Banton, OD, PhD</last_name>
    <phone>434-924-8656</phone>
    <email>tab2v@hscmail.mcc.virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel J Cox, PhD</last_name>
    <phone>434-924-8021</phone>
    <email>djc4f@virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Psychiatry and Neurobehavioral Sciences, University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.diabetes.org/living-with-diabetes/complications/</url>
    <description>American Diabetes Association (2012). Living with diabetes: Complications. Retrieved on 5/17/15</description>
  </link>
  <reference>
    <citation>Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19. Review. Erratum in: Diabetes Care. 2013 Feb;36(2):490.</citation>
    <PMID>22517736</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Gill Taylor A, Dunning ES, Winston MC, Luk Van IL, McCall A, Singh H, Yancy WS Jr. Impact of behavioral interventions in the management of adults with type 2 diabetes mellitus. Curr Diab Rep. 2013 Dec;13(6):860-8. doi: 10.1007/s11892-013-0423-7. Review.</citation>
    <PMID>24072477</PMID>
  </reference>
  <reference>
    <citation>Hill JO, Galloway JM, Goley A, Marrero DG, Minners R, Montgomery B, Peterson GE, Ratner RE, Sanchez E, Aroda VR. Scientific statement: Socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care. 2013 Aug;36(8):2430-9. doi: 10.2337/dc13-1161. Epub 2013 Jun 20. Review.</citation>
    <PMID>23788649</PMID>
  </reference>
  <reference>
    <citation>Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.</citation>
    <PMID>22079683</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6.</citation>
    <PMID>23468086</PMID>
  </reference>
  <reference>
    <citation>Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999 Jun 2;281(21):2005-12.</citation>
    <PMID>10359389</PMID>
  </reference>
  <reference>
    <citation>Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis. 2006 Oct;16(7):453-6. Epub 2006 Aug 24.</citation>
    <PMID>16934443</PMID>
  </reference>
  <reference>
    <citation>Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Erratum in: Lancet. 2009 Dec 19;374(9707):2054.</citation>
    <PMID>19878986</PMID>
  </reference>
  <reference>
    <citation>Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010 Sep 27;170(17):1566-75. doi: 10.1001/archinternmed.2010.334.</citation>
    <PMID>20876408</PMID>
  </reference>
  <reference>
    <citation>Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.</citation>
    <PMID>18539917</PMID>
  </reference>
  <reference>
    <citation>Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007 Jun;30(6):1374-83. Epub 2007 Mar 15.</citation>
    <PMID>17363746</PMID>
  </reference>
  <reference>
    <citation>DiPietro L, Gribok A, Stevens MS, Hamm LF, Rumpler W. Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care. 2013 Oct;36(10):3262-8. doi: 10.2337/dc13-0084. Epub 2013 Jun 11.</citation>
    <PMID>23761134</PMID>
  </reference>
  <reference>
    <citation>Mayer-Davis EJ, D'Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998 Mar 4;279(9):669-74.</citation>
    <PMID>9496984</PMID>
  </reference>
  <reference>
    <citation>Ingersoll KS, Banton T, Gorlin E, Vajda K, Singh H, Peterson N, Gonder-Frederick L, Cox DJ. Motivational Interviewing Support for a Behavioral Health Internet Intervention for Drivers with Type 1 Diabetes. Internet Interv. 2015 May 1;2(2):103-109.</citation>
    <PMID>25774342</PMID>
  </reference>
  <reference>
    <citation>Høstmark AT, Ekeland GS, Beckstrøm AC, Meen HD. Postprandial light physical activity blunts the blood glucose increase. Prev Med. 2006 May;42(5):369-71. Epub 2006 Mar 20.</citation>
    <PMID>16549107</PMID>
  </reference>
  <reference>
    <citation>Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003 Mar;52(3):581-7. Review.</citation>
    <PMID>12606496</PMID>
  </reference>
  <reference>
    <citation>Heinemann L. (Analytical) accuracy of blood glucose meters and patients: how do they come together? J Diabetes Sci Technol. 2013 Jan 1;7(1):1-3.</citation>
    <PMID>23439154</PMID>
  </reference>
  <reference>
    <citation>Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2015 Mar;17(3):177-86. doi: 10.1089/dia.2014.0272. Epub 2014 Dec 1.</citation>
    <PMID>25436913</PMID>
  </reference>
  <reference>
    <citation>Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015 Mar;9(2):209-14. doi: 10.1177/1932296814559746. Epub 2014 Nov 3.</citation>
    <PMID>25370149</PMID>
  </reference>
  <reference>
    <citation>Allen NA, Jacelon CS, Chipkin SR. Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes. J Clin Nurs. 2009 Feb;18(3):373-83. doi: 10.1111/j.1365-2702.2008.02533.x.</citation>
    <PMID>19191984</PMID>
  </reference>
  <reference>
    <citation>Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Res Clin Pract. 2008 Jun;80(3):371-9. doi: 10.1016/j.diabres.2008.01.006. Epub 2008 Mar 4.</citation>
    <PMID>18304674</PMID>
  </reference>
  <reference>
    <citation>Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012 Jan;35(1):32-8. doi: 10.2337/dc11-1438. Epub 2011 Nov 18.</citation>
    <PMID>22100963</PMID>
  </reference>
  <reference>
    <citation>Fonda SJ, Salkind SJ, Walker MS, Chellappa M, Ehrhardt N, Vigersky RA. Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application. Diabetes Care. 2013 Apr;36(4):786-92. doi: 10.2337/dc12-1225. Epub 2012 Nov 19.</citation>
    <PMID>23172975</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Tisdelle DA, Culbert JP. Increasing adherence to behavioral homework assignments. J Behav Med. 1988 Oct;11(5):519-22.</citation>
    <PMID>3236383</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Taylor AG, Nowacek G, Holley-Wilcox P, Pohl SL, Guthrow E. The relationship between psychological stress and insulin-dependent diabetic blood glucose control: preliminary investigations. Health Psychol. 1984;3(1):63-75.</citation>
    <PMID>6536483</PMID>
  </reference>
  <reference>
    <citation>Cox D, Gonder-Frederick L, McCall A, Kovatchev B, Clarke W. The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. Int J Clin Pract Suppl. 2002 Jul;(129):20-6. Review.</citation>
    <PMID>12166601</PMID>
  </reference>
  <reference>
    <citation>Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr; American Diabetes Association. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013 Nov;36(11):3821-42. doi: 10.2337/dc13-2042. Epub 2013 Oct 9.</citation>
    <PMID>24107659</PMID>
  </reference>
  <reference>
    <citation>Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care. 2000 Jun;23(6):739-43.</citation>
    <PMID>10840988</PMID>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, Kokoszka A, Matthews D, Pibernik-Okanović M, Rodríguez-Saldaña J, de Wit M, Snoek FJ. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010 Jan;53(1):66-9. doi: 10.1007/s00125-009-1559-5. Epub 2009 Oct 20.</citation>
    <PMID>19841892</PMID>
  </reference>
  <reference>
    <citation>Subar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C, Willis G, Islam NG, Baranowski T, McNutt S, Potischman N. The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet. 2012 Aug;112(8):1134-7. doi: 10.1016/j.jand.2012.04.016. Epub 2012 Jun 15.</citation>
    <PMID>22704899</PMID>
  </reference>
  <reference>
    <citation>Taylor WJ, Myers J, Simpson RT, McPherson KM, Weatherall M. Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): score distributions and psychometric properties. Arthritis Rheum. 2004 Jun 15;51(3):350-7.</citation>
    <PMID>15188318</PMID>
  </reference>
  <reference>
    <citation>Camarri B, Eastwood PR, Cecins NM, Thompson PJ, Jenkins S. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med. 2006 Apr;100(4):658-65. Epub 2005 Oct 17.</citation>
    <PMID>16229997</PMID>
  </reference>
  <reference>
    <citation>Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS; 2013 ACC/AHA Cholesterol Guideline Panel. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med. 2014 Mar 4;160(5):339-43. doi: 10.7326/M14-0126.</citation>
    <PMID>24474185</PMID>
  </reference>
  <reference>
    <citation>Mayer SB, Jeffreys AS, Olsen MK, McDuffie JR, Feinglos MN, Yancy WS Jr. Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. Diabetes Obes Metab. 2014 Jan;16(1):90-3. doi: 10.1111/dom.12191. Epub 2013 Aug 29.</citation>
    <PMID>23911112</PMID>
  </reference>
  <reference>
    <citation>Oldroyd J, Banerjee M, Heald A, Cruickshank K. Diabetes and ethnic minorities. Postgrad Med J. 2005 Aug;81(958):486-90. Review.</citation>
    <PMID>16085737</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Taylor AG, Singh H, Moncrief M, Diamond A, Yancy WS Jr, Hegde S, McCall AL. Glycemic load, exercise, and monitoring blood glucose (GEM): A paradigm shift in the treatment of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016 Jan;111:28-35. doi: 10.1016/j.diabres.2015.10.021. Epub 2015 Oct 21.</citation>
    <PMID>26556234</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Taylor AG, Moncrief M, Diamond A, Yancy WS Jr, Hegde S, McCall AL. Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift. Diabetes Care. 2016 May;39(5):e71-3. doi: 10.2337/dc15-2836. Epub 2016 Mar 17.</citation>
    <PMID>26989181</PMID>
  </reference>
  <reference>
    <citation>Brunk DR, Taylor AG, Clark ML, Williams IC, Cox DJ. A Culturally Appropriate Self-Management Program for Hispanic Adults With Type 2 Diabetes and Low Health Literacy Skills. J Transcult Nurs. 2017 Mar;28(2):187-194. doi: 10.1177/1043659615613418. Epub 2016 Jul 9.</citation>
    <PMID>26525585</PMID>
  </reference>
  <reference>
    <citation>Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27;344:e486. doi: 10.1136/bmj.e486.</citation>
    <PMID>22371867</PMID>
  </reference>
  <reference>
    <citation>Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalová L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015 Nov 19;163(5):1079-1094. doi: 10.1016/j.cell.2015.11.001.</citation>
    <PMID>26590418</PMID>
  </reference>
  <reference>
    <citation>Hinderliter AL, Sherwood A, Craighead LW, Lin PH, Watkins L, Babyak MA, Blumenthal JA. The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am J Hypertens. 2014 May;27(5):734-41. doi: 10.1093/ajh/hpt183. Epub 2013 Oct 1.</citation>
    <PMID>24084586</PMID>
  </reference>
  <reference>
    <citation>Jelleyman C, Yates T, O'Donovan G, Gray LJ, King JA, Khunti K, Davies MJ. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev. 2015 Nov;16(11):942-61. doi: 10.1111/obr.12317. Review.</citation>
    <PMID>26481101</PMID>
  </reference>
  <reference>
    <citation>Miller CK, Kristeller JL, Headings A, Nagaraja H. Comparison of a mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: a randomized controlled trial. Health Educ Behav. 2014 Apr;41(2):145-54. doi: 10.1177/1090198113493092. Epub 2013 Jul 12.</citation>
    <PMID>23855018</PMID>
  </reference>
  <reference>
    <citation>Ekong G, Kavookjian J. Motivational interviewing and outcomes in adults with type 2 diabetes: A systematic review. Patient Educ Couns. 2016 Jun;99(6):944-52. doi: 10.1016/j.pec.2015.11.022. Epub 2015 Dec 4. Review.</citation>
    <PMID>26699083</PMID>
  </reference>
  <reference>
    <citation>Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002 Jul;76(1):5-56.</citation>
    <PMID>12081815</PMID>
  </reference>
  <reference>
    <citation>Parkin CG, Buskirk A, Hinnen DA, Axel-Schweitzer M. Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Res Clin Pract. 2012 Jul;97(1):6-15. doi: 10.1016/j.diabres.2012.03.002. Epub 2012 Mar 30. Review.</citation>
    <PMID>22464874</PMID>
  </reference>
  <reference>
    <citation>Polonsky WH, Fisher L. Self-monitoring of blood glucose in noninsulin-using type 2 diabetic patients: right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users. Diabetes Care. 2013 Jan;36(1):179-82. doi: 10.2337/dc12-0731.</citation>
    <PMID>23264290</PMID>
  </reference>
  <reference>
    <citation>Tsalatsanis A, Gil-Herrera E, Yalcin A, Djulbegovic B, Barnes L. Designing patient-centric applications for chronic disease management. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:3146-9. doi: 10.1109/IEMBS.2011.6090858.</citation>
    <PMID>22255007</PMID>
  </reference>
  <reference>
    <citation>Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001 Apr;24(4):637-42.</citation>
    <PMID>11315822</PMID>
  </reference>
  <reference>
    <citation>Cox D, Ritterband L, Magee J, Clarke W, Gonder-Frederick L. Blood glucose awareness training delivered over the internet. Diabetes Care. 2008 Aug;31(8):1527-8. doi: 10.2337/dc07-1956. Epub 2008 May 13.</citation>
    <PMID>18477813</PMID>
  </reference>
  <reference>
    <citation>Jilcott S, Ammerman A, Sommers J, Glasgow RE. Applying the RE-AIM framework to assess the public health impact of policy change. Ann Behav Med. 2007 Oct;34(2):105-14.</citation>
    <PMID>17927550</PMID>
  </reference>
  <reference>
    <citation>Augustin LS, Kendall CW, Jenkins DJ, Willett WC, Astrup A, Barclay AW, Björck I, Brand-Miller JC, Brighenti F, Buyken AE, Ceriello A, La Vecchia C, Livesey G, Liu S, Riccardi G, Rizkalla SW, Sievenpiper JL, Trichopoulou A, Wolever TM, Baer-Sinnott S, Poli A. Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):795-815. doi: 10.1016/j.numecd.2015.05.005. Epub 2015 May 16.</citation>
    <PMID>26160327</PMID>
  </reference>
  <reference>
    <citation>Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH, Schwarz P; IMAGE Study Group. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health. 2011 Feb 18;11:119. doi: 10.1186/1471-2458-11-119. Review.</citation>
    <PMID>21333011</PMID>
  </reference>
  <reference>
    <citation>Runchey SS, Pollak MN, Valsta LM, Coronado GD, Schwarz Y, Breymeyer KL, Wang C, Wang CY, Lampe JW, Neuhouser ML. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study. Eur J Clin Nutr. 2012 Oct;66(10):1146-52. doi: 10.1038/ejcn.2012.107. Epub 2012 Aug 15.</citation>
    <PMID>22892437</PMID>
  </reference>
  <reference>
    <citation>Liu AG, Most MM, Brashear MM, Johnson WD, Cefalu WT, Greenway FL. Reducing the glycemic index or carbohydrate content of mixed meals reduces postprandial glycemia and insulinemia over the entire day but does not affect satiety. Diabetes Care. 2012 Aug;35(8):1633-7. doi: 10.2337/dc12-0329. Epub 2012 Jun 11.</citation>
    <PMID>22688548</PMID>
  </reference>
  <reference>
    <citation>Colberg SR, Grieco CR, Somma CT. Exercise effects on postprandial glycemia, mood, and sympathovagal balance in type 2 diabetes. J Am Med Dir Assoc. 2014 Apr;15(4):261-6. doi: 10.1016/j.jamda.2013.11.026. Epub 2014 Feb 6.</citation>
    <PMID>24508328</PMID>
  </reference>
  <reference>
    <citation>Turcotte LP, Fisher JS. Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise. Phys Ther. 2008 Nov;88(11):1279-96. doi: 10.2522/ptj.20080018. Epub 2008 Sep 18. Review.</citation>
    <PMID>18801860</PMID>
  </reference>
  <reference>
    <citation>Rynders CA, Weltman JY, Jiang B, Breton M, Patrie J, Barrett EJ, Weltman A. Effects of exercise intensity on postprandial improvement in glucose disposal and insulin sensitivity in prediabetic adults. J Clin Endocrinol Metab. 2014 Jan;99(1):220-8. doi: 10.1210/jc.2013-2687. Epub 2013 Dec 20.</citation>
    <PMID>24243632</PMID>
  </reference>
  <reference>
    <citation>Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, Bonizzoni E, Giorgino F; PRISMA Study Group. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care. 2013 Oct;36(10):2887-94. doi: 10.2337/dc13-0092. Epub 2013 Jun 4.</citation>
    <PMID>23735724</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2016</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Daniel Cox, PhD</investigator_full_name>
    <investigator_title>Professor, Departments of Psychiatry, Internal Medicine and Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Continuous Glucose Monitoring</keyword>
  <keyword>Lifestyle Modification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

